Lan Yang
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- RNA Research and Splicing
Papers in
-
- RNA modifications and cancer 8
- Epigenetics and DNA Methylation 6
- Cancer-related gene regulation 5
-
- MicroRNA in disease regulation 8
- Cancer-related molecular mechanisms research 6
- Co-authors
- Michael R. Stallcup (4 shared papers)Heng Hong (3 shared papers)Jianming Hu (10 shared papers)Xiaobin Cui (13 shared papers)Yunzhao Chen (9 shared papers)Donald Defranco (2 shared papers)Hao Peng (3 shared papers)Hong Zhou (2 shared papers)
- Journals
- Epigenetics (2 papers)Journal of Experimental & Clinical Cancer Research (2 papers)Advances in experimental medicine and biology (2 papers)Journal of Biological Chemistry (2 papers)Molecular Cancer (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Lan Yang
56 papers receiving 1.6k citations
Lan Yang's Hit Papers
Peers
Comparison fields: 5 of 107
- Cancer Research 379
- Molecular Biology 959
- Genetics 319
- Immunology 211
- Oncology 238
Countries citing papers authored by Lan Yang
This map shows the geographic impact of Lan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lan Yang more than expected).
Fields of papers citing papers by Lan Yang
This network shows the impact of papers produced by Lan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lan Yang. The network helps show where Lan Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lan Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression Hit paper breakdown → | 2019 | 321 |
| 2 | 1999 | 260 | |
| 3 | 2000 | 116 | |
| 4 | 1999 | 75 | |
| 5 | 2015 | 72 | |
| 6 | 2015 | 65 | |
| 7 | 2017 | 59 | |
| 8 | 2017 | 52 | |
| 9 | 2019 | 52 | |
| 10 | 2019 | 44 | |
| 11 | 2013 | 41 | |
| 12 | 2010 | 35 | |
| 13 | 2015 | 30 | |
| 14 | 2013 | 27 | |
| 15 | 2004 | 24 | |
| 16 | 2009 | 23 | |
| 17 | 2017 | 22 | |
| 18 | 2014 | 21 | |
| 19 | 2019 | 21 | |
| 20 | 2015 | 20 |
About Lan Yang
Lan Yang is a scholar working on Molecular Biology, Cancer Research, Immunology, Oncology and Genetics, having authored 61 papers that have together received 1.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (8 papers), RNA modifications and cancer (8 papers), Epigenetics and DNA Methylation (6 papers), Cancer-related molecular mechanisms research (6 papers), Immune cells in cancer (5 papers), Cancer-related gene regulation (5 papers), Estrogen and related hormone effects (3 papers) and Endoplasmic Reticulum Stress and Disease (3 papers). The work is most often cited by research in Cancer Research (379 citations), Molecular Biology (959 citations), Genetics (319 citations), Immunology (211 citations) and Oncology (238 citations). Lan Yang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Michael R. Stallcup, Heng Hong, Jianming Hu, Xiaobin Cui, Yunzhao Chen, Donald Defranco, Hao Peng, Hong Zhou, Dandan Wang and Feng Li. Their work appears in journals such as Epigenetics, Journal of Experimental & Clinical Cancer Research, Advances in experimental medicine and biology, Journal of Biological Chemistry and Molecular Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.